Please login to the form below

Not currently logged in
Email:
Password:

acquisitions

This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

Oelkers concluded: "We see the acquisition as a stepping stone to drive sustainable growth in the US and make Sobi more attractive for partnering. ... The expected earnings of this acquisition will increase the financial flexibility to support further

Latest news

More from news
Approximately 175 fully matching, plus 1,071 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 79 partially matching documents found.

Latest appointments

  • Biogen appoints executive VP, corporate development Biogen appoints executive VP, corporate development

    In that role, he led a global team responsible for early science transactions, partnerships and acquisitions across Pfizer's research portfolio.

  • Smith & Nephew name new CEO Smith & Nephew name new CEO

    Nawana has joined Smith &Nephew from medical diagnostics company Alere, where he was also chief executive officer, and oversaw its $5.3bn acquisition by Abbott last year.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Previously, Mullen has served as chief executive officer of Patheon, a pharmaceutical development and manufacturing services provider, until its acquisition by Thermo Fisher Scientific last year.

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    acquisition of drug candidates, commercial products and companies for the global speciality drug business. ... With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy,

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    Mere weeks after completing its acquisition of CAR-T specialist Juno, Celgene has added to its cell therapy pipeline with another clinical-stage CAR-T candidate from Bluebird Bio. ... The firmed-up deal with Bluebird comes after Celgene completed its

More from appointments
Approximately 0 fully matching, plus 115 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 88 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics